178 related articles for article (PubMed ID: 35106503)
1. Circulating Tumor DNA in Patients with Renal Cell Carcinoma. A Systematic Review of the Literature.
Geertsen L; Koldby KM; Thomassen M; Kruse T; Lund L
Eur Urol Open Sci; 2022 Mar; 37():27-35. PubMed ID: 35106503
[TBL] [Abstract][Full Text] [Related]
2. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112
[TBL] [Abstract][Full Text] [Related]
3. Methylated Circulating Tumor DNA in Blood as a Tool for Diagnosing Lung Cancer: A Systematic Review and Meta-Analysis.
Borg M; Wen SWC; Andersen RF; Timm S; Hansen TF; Hilberg O
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568774
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor DNA as a Predictive and Prognostic Biomarker in the Perioperative Treatment of Muscle-invasive Bladder Cancer: A Systematic Review.
Crupi E; de Padua TC; Marandino L; Raggi D; Dyrskjøt L; Spiess PE; Sonpavde GP; Kamat AM; Necchi A
Eur Urol Oncol; 2024 Feb; 7(1):44-52. PubMed ID: 37330413
[TBL] [Abstract][Full Text] [Related]
5. Exploring Circulating Tumor DNA (CtDNA) and Its Role in Early Detection of Cancer: A Systematic Review.
Bittla P; Kaur S; Sojitra V; Zahra A; Hutchinson J; Folawemi O; Khan S
Cureus; 2023 Sep; 15(9):e45784. PubMed ID: 37745752
[TBL] [Abstract][Full Text] [Related]
6. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
[TBL] [Abstract][Full Text] [Related]
7. Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature.
Green EA; Li R; Albiges L; Choueiri TK; Freedman M; Pal S; Dyrskjøt L; Kamat AM
Eur Urol Oncol; 2021 Dec; 4(6):893-903. PubMed ID: 33975782
[TBL] [Abstract][Full Text] [Related]
8. Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma.
Bacon JVW; Annala M; Soleimani M; Lavoie JM; So A; Gleave ME; Fazli L; Wang G; Chi KN; Kollmannsberger CK; Wyatt AW; Nappi L
Clin Genitourin Cancer; 2020 Aug; 18(4):322-331.e2. PubMed ID: 32046920
[TBL] [Abstract][Full Text] [Related]
9. The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review.
Cree IA; Uttley L; Buckley Woods H; Kikuchi H; Reiman A; Harnan S; Whiteman BL; Philips ST; Messenger M; Cox A; Teare D; Sheils O; Shaw J;
BMC Cancer; 2017 Oct; 17(1):697. PubMed ID: 29061138
[TBL] [Abstract][Full Text] [Related]
10. The Role of Circulating Tumor DNA in Renal Cell Carcinoma.
Bergerot PG; Hahn AW; Bergerot CD; Jones J; Pal SK
Curr Treat Options Oncol; 2018 Feb; 19(2):10. PubMed ID: 29464405
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses.
van Rees JM; Wullaert L; Grüter AAJ; Derraze Y; Tanis PJ; Verheul HMW; Martens JWM; Wilting SM; Vink G; van Vugt JLA; Beije N; Verhoef C
Front Oncol; 2023; 13():1083285. PubMed ID: 36793616
[TBL] [Abstract][Full Text] [Related]
12. Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review.
Thusgaard CF; Korsholm M; Koldby KM; Kruse TA; Thomassen M; Jochumsen KM
Gynecol Oncol; 2021 Jun; 161(3):884-895. PubMed ID: 33892886
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma.
Yamamoto Y; Uemura M; Fujita M; Maejima K; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kinouchi T; Hayashi T; Matsuzaki K; Jingushi K; Kato T; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Nakagawa H; Nonomura N
Cancer Sci; 2019 Feb; 110(2):617-628. PubMed ID: 30536551
[TBL] [Abstract][Full Text] [Related]
14. Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma.
Glennon KI; Maralani M; Abdian N; Paccard A; Montermini L; Nam AJ; Arseneault M; Staffa A; Jandaghi P; Meehan B; Brimo F; Tanguay S; Rak J; Riazalhosseini Y
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830979
[TBL] [Abstract][Full Text] [Related]
15. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
16. Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma.
Pal SK; Sonpavde G; Agarwal N; Vogelzang NJ; Srinivas S; Haas NB; Signoretti S; McGregor BA; Jones J; Lanman RB; Banks KC; Choueiri TK
Eur Urol; 2017 Oct; 72(4):557-564. PubMed ID: 28413127
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review.
Lommen K; Vaes N; Aarts MJ; van Roermund JG; Schouten LJ; Oosterwijk E; Melotte V; Tjan-Heijnen VC; van Engeland M; Smits KM
Eur Urol Oncol; 2021 Apr; 4(2):215-226. PubMed ID: 31402218
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis.
Creemers A; Krausz S; Strijker M; van der Wel MJ; Soer EC; Reinten RJ; Besselink MG; Wilmink JW; van de Vijver MJ; van Noesel CJM; Verheij J; Meijer SL; Dijk F; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):394-403. PubMed ID: 28801248
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: A systematic review and meta-analysis.
Papakonstantinou A; Gonzalez NS; Pimentel I; Suñol A; Zamora E; Ortiz C; Espinosa-Bravo M; Peg V; Vivancos A; Saura C; Villacampa G; Oliveira M
Cancer Treat Rev; 2022 Mar; 104():102362. PubMed ID: 35219090
[TBL] [Abstract][Full Text] [Related]
20. Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review.
Bach S; Sluiter NR; Beagan JJ; Mekke JM; Ket JCF; van Grieken NCT; Steenbergen RDM; Ylstra B; Kazemier G; Tuynman JB
JNCI Cancer Spectr; 2019 Sep; 3(3):pkz042. PubMed ID: 32328554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
